Liver tumors in children

Oncologist

Volumn 13, Issue 7, 2008, Pages 812-820

  Litten, Jason B ^a   Tomlinson, Gail E ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Hepatoblastoma; Liver tumor; Pediatric cancer

Indexed keywords

ALPHA FETOPROTEIN; CARBOPLATIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CISPLATIN; DOXORUBICIN; FLUOROURACIL; HEPATITIS B VACCINE; IFOSFAMIDE; SORAFENIB; VINCRISTINE;

ADENOMATOUS POLYP; ADVANCED CANCER; ALAGILLE SYNDROME; ANGIOMYOLIPOMA; ANGIOSARCOMA; ATAXIA TELANGIECTASIA; BECKWITH WIEDEMANN SYNDROME; BILIARY ADENOMA; BILIARY TRACT TUMOR; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CHOLESTASIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; EMBRYONAL CARCINOMA; ENVIRONMENTAL FACTOR; FAMILIAL CANCER; FANCONI ANEMIA; GENE LOCUS; GERM CELL TUMOR; GLYCOGEN STORAGE DISEASE TYPE 1; HAMARTOMA; HEMANGIOENDOTHELIOMA; HEPATOBLASTOMA; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT MORTALITY; LIVER ADENOMA; LIVER CANCER; LIVER CELL CARCINOMA; LIVER SARCOMA; LIVER TRANSPLANTATION; LIVER TUMOR; LUNG METASTASIS; METASTASIS; MULTIPLE CYCLE TREATMENT; NEURILEMOMA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERINATAL PERIOD; PREMATURITY; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; RHABDOID TUMOR; TRISOMY 18; TUBEROUS SCLEROSIS; TYROSINEMIA; VASCULAR TUMOR;

CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; HEPATOBLASTOMA; HUMANS; INFANT; INFANT, NEWBORN; LIVER NEOPLASMS; LIVER TRANSPLANTATION; SARCOMA;

EID: 48749093455     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2008-0011     Document Type: Review

References (60)

1. Multerys M, Goodman MT, Smith MA et al. Hepatic Tumors. In Ries LAG, Smith MA, Gurney JG et al. (eds). Cancer Incidence, Survival among Children, Adolescents: United States SEER Program 1975-1995. SEER Program, NIH Pub. No 99-4649. Bethesda, MD: National Cancer Institute, 1999:91-97.
2. Weinberg AG, Finegold MJ. Primary hepatic tumors of childhood. Hum Pathology 1983;14:512-537.
3. Kenney LB, Miller BA, Ries LA et al. Incidence of cancer in infants in the U.S.: 1980-1990. Cancer 1998;82:1396-1400.
4. Ikeda H, Matsuyama S, Tanimura M. Association between hepatoblastoma and very low birth weight: A trend or chance? J Pediatr 1997;130:557-560.
5. Reynolds P, Urayama KY, Von Behren J et al. Birth characteristics and hepatoblastoma risk in young children. Cancer 2004;100:1070-1076.
6. Spector LG, Feusner JH, Ross JA. Hepatoblastoma and low birth weight. Pediatr Blood Cancer 2004;43:706.
7. Ruck P, Xiao JC, Pietsch T et al. Hepatic stem-like cells in hepatoblastoma: Expression of cytokeratin 7, albumin and oval cell associated antigens detected by OV-1 and OV-6. Histopathology 1997;31:324-329.
8. Ruck P, Xiao JC. Stem-like cells in hepatoblastoma. Med Pediatr Oncol 2002;39:504-507.
9. Exelby PR, Filler RM, Grosfeld JL. Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey-1974. J Pediatr Surg 1975;10:329-337.
10. Haas JE, Feusner JH, Finegold MJ. Small cell undifferentiated histology in hepatoblastoma may be unfavorable. Cancer 2001;92:3130-3134.
11. Chen JC, Chang ML, Lin JN et al. Comparison of childhood hepatic malignancies in a hepatitis B hyper-endemic area. World J Gastroenterol 2005;11:5289-5294.
12. Chang MH, Chen CJ, Lai MS et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336:1855-1859.
13. Bisogno G, Pilz T, Perilongo G et al. Undifferentiated sarcoma of the liver in childhood: A curable disease. Cancer 2002;94:252-257.
14. Lack EE, Schloo BL, AzumiNet al. Undifferentiated (embryonal) sarcoma of the liver. Clinical and pathological study of 16 cases with emphasis on immunohistochemical features. Am J Surg Pathol 1991;15:1-16.
15. Awan S, Davenport M, Portmann B et al. Angiosarcoma of the liver in children. J Pediatr Surg 1996;31:1729-1732.
16. Dimashkieh HH, Mo JQ, Wyatt-Ashmead J et al. Pediatric hepatic angiosarcoma: Case report and review of the literature. Pediatr Dev Pathol 2004;7:527-532.
17. Nicol K, Savell V, Moore J et al.; Children's Oncology Group, Soft Tissue Sarcoma Committee. Distinguishing undifferentiated embryonal sarcoma of the liver from biliary tract rhabdomyosarcoma: A Children's Oncology Group study. Pediatr Dev Pathol 2007;10:89-97.
18. Verma M, Agarwal S, Mohta A. Primary mixed germ cell tumour of the liver - a case report. Indian J Pathol Microbiol 2003;46:658-659.
19. Brodeur GM, Howarth CB, Pratt CB et al. Malignant germ cell tumors in 57 children and adolescents. Cancer 1981;48:1890-1898.
20. Reddy KR, Kligerman S, Levi J et al. Benign and solid tumors of the liver: Relationship to sex, age, size of tumors, and outcome. Am Surg 2001;67:173-178.
21. Selby DM, Stocker JT, Waclawiw MA et al. Infantile hemangioendothelioma of the liver. Hepatology 1994;20:39-45.
22. Skopec LL, Lakutua DJ. Non-immune fetal hydrops with hepatic hemangioendothelioma and Kasabach-Merrit syndrome: A case report. Pediatr Pathol 1989;9:87-93.
23. Prokurat A, Kluge P, Chrupek M et al. Hemangioma of the liver in children: Proliferating vascular tumor or congenital vascular malformation. Med Pediatr Oncol 2002;39:524-529.
24. Burrows PE, Dubois J, Kassarjian A. Pediatric hepatic vascular anomalies. Pediatr Radiol 2001;31:533-545.
25. Siddiqui MA, McKenna BJ. Hepatic mesenchymal hamartoma: A short review. Arch Pathol Lab Med 2006;130:1567-1569.
26. Kingston JE, Herbert A, Draper GJ et al. Association between hepatoblastoma and polyposis coli. Arch Dis Child 1983;58:959-962.
27. DeBaun MR, Tucker MA. Risk of cancer during the first four years of life in children from the Beckwith-Wiedemann Syndrome Registry. J Pediatr 1998;132:398-400.
28. Rainier S, Dobry CJ, Feinberg AP. Loss of imprinting in hepatoblastoma. Cancer Res 1995;55:1836-1838.
29. Park WS, Oh RR, Park JY et al. Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma. J Pathol 2001;193:483-490.
30. Monga SP, Mars WM, Pediaditakis P et al. Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes. Cancer Res 2002;62:2064-2071.
31. Tomlinson GE, Douglass EC, Pollock BH et al. Cytogenetic evaluation of a large series of hepatoblastomas: Numerical abnormalities with recurring aberrations involving 1q12-q21. Genes Chromosomes Cancer 2005;44:177-184.
32. Schneider NR, Cooley LD, Finegold MJ et al. The first recurring chromosome translocation in hepatoblastoma: der(4)t(1;4)(q12;q34). Genes Chromosomes Cancer 1997;19:291-294.
33. Parada LA, Limon J, Iliszko M et al. Cytogenetics of hepatoblastoma: Further characterization of 1q rearrangements by fluorescence in situ hybridization: An International collaborative study. Med Pediatr Oncol 2000;34:165-170.
34. Shim YH, Park HJ, Choi MS et al. Hypermethylation of the p16 gene and lack of p16 expression in hepatoblastoma. Mod Pathol 2003;16:430-436.
35. Buckley JD, Sather H, Ruccione K et al. A case-control study of risk factors for hepatoblastoma. A report from the Children's Cancer Study Group. Cancer 1989;64:1169-1176.
36. Pang D, McNally R, Birch JM. Parental smoking and childhood cancer: Results from the United Kingdom Childhood Cancer Study. Br J Cancer 2003;88:373-381.
37. Sorahan T, Lancashire RJ. Parental cigarette smoking and childhood risks of hepatoblastoma: OSCC data. Br J Cancer 2004;90:1016-1018.
38. Komura E, Matsusumura T, Kato T et al. Thrombopoietin in patients with hepatoblastoma. STEM CELLS 1998;16:329-333.
39. Van Tornout JM, Buckley JD, Quinn JJ et al. Timing and magnitude of decline in apha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: A report from the Children's Cancer Group. J Clin Oncol 1997;15:1190-1197.
40. Roebuck DJ, Aronson D, Clapuyt P et al. 2005 PRETEXT: A revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol 2007;37:123-132.
41. Brown J, Perilongo G, Shafford E et al. Pretreatment prognostic factors for children with hepatoblastoma - results from the International Society of Pediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer 2000;36:1418-1425.
42. Aronson DC, Schnater JM, Staalman CR et al. Predictive value of pretreatment extent of disease system in hepatoblastoma: Results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study. J Clin Oncol 2005;23:1245-1262.
43. Tiao GM, Bobey N, Allen S et al. The current management of hepatoblastoma: A combination of chemotherapy, conventional resection, and liver transplantation. J Pediatr 2005;146:204-211.
44. Zhu AX. Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma. Cancer 2008;112:250-259.
45. Czauderna P, Otte JB, Roebuck DJ al. Surgical treatment of hepatoblastoma in children. Pediatr Radiol 2006;36:187-191.
46. Ortega JA, Douglass EC, Feusner JH et al. Randomized comparison of cisplatin/vincristine/fluorouracil and continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol 2000;18:2665-2675.
47. Pritchard J, Brown J, Shafford E et al. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: A successful approach - results of the first prospective study of the International Society of Pediatric Oncology. J Clin Oncol 2000;18:3819-3828.
48. Cromheecke M, Konings AW, Szabo BG et al. Liver tissue tolerance for irradiation: Experimental and clinical investigations. Hepatogastroenterology 2000;47:1732-1740.
49. Otte JB, de Ville de Goyet J, Reding R. Liver transplantation for hepatoblastoma: Indications and contraindications in the modern era. Pediatr Transplant 2005;9:557-565.
50. Reyes JD, Carr B, Dvorchik I et al. Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence. J Pediatr 2000;136:795-804.
51. Otte JB, Pritchard J, Aronson DC et al. Liver transplantation for hepatoblastoma: Results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer 2004;42:74-83.
52. Figrola MS, McQuiston SA, Wilson F et al. Recurrent hepatoblastoma with localization by PET-CT. Pediatr Radiol 2005;35:1254-1258.
53. Kairemo KJ, Lindahl H, Merenmies J et al. Anti alpha-fetoprotein imaging is useful for staging in hepatoblastoma. Transplantation 2002;73:1151-1154.
54. Czauderna P, Otte JB, Aronson DC et al. Guidelines for surgical treatment of hepatoblastoma in the modern era - recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL). Eur J Cancer 2005;41:1031-1036.
55. Abramson LP, Arensman R. Liver Tumors. Available at http://www.emedicine. com/ped/topic3035.htm. Accessed December 27, 2007.
56. Douglass EC, Reynolds M, Finegold M et al. Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: A Pediatric Oncology Group study. J Clin Oncol 1993;11:96-99.
57. Katzenstein HM, London WB, Douglass EC et al. Treatment of unresectable and metastatic hepatoblastoma: A Pediatric Oncology Group phase II study. J Clin Oncol 2002;20:3438-3444.
58. Von Schweinitz D, Byrd DJ, Hecker H et al. Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology. Eur J Cancer 1997;33:1243-1249.
59. Fuchs J, Rydzynski J, Von Schweinitz D et al. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: A report from the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer 2002;95:172-182.
60. Perilongo G, Shafford E, Maibach R et al. Risk-adapted treatment for childhood hepatoblastoma: Final report of the second study of the International Society of Paediatric Oncology - SIOPEL 2. Eur J Cancer 2004;40: 411-421.